QC
HCAT icon

Quadrature Capital’s Health Catalyst HCAT Stock Holding History

Quadrature Capital’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,888
Closed -$64.3K – 1589
2025
Q4 		$64.3K Buy
+26,888
New +$73.5K ﹤0.01% 1150
2024
Q4 		– Sell
-10,292
Closed -$83.8K – 1194
2024
Q3 		$83.8K Buy
+10,292
New +$74.4K ﹤0.01% 877
2023
Q1 		– Sell
-105,206
Closed -$1.12M – 1031
2022
Q4 		$1.12M Sell
105,206
-64,112
-38% -$619K 0.03% 329
2022
Q3 		$1.64M Buy
169,318
+137,902
+439% +$1.83M 0.05% 288
2022
Q2 		$456K Buy
+31,416
New +$536K 0.02% 441
2021
Q4 		– Sell
-6,712
Closed -$336K – 798
2021
Q3 		$336K Sell
6,712
-18,901
-74% -$1.03M 0.01% 471
2021
Q2 		$1.42M Buy
25,613
+7,096
+38% +$378K 0.05% 244
2021
Q1 		$865K Sell
18,517
-10,084
-35% -$488K 0.04% 343
2020
Q4 		$1.25M Buy
28,601
+6,398
+29% +$236K 0.06% 261
2020
Q3 		$812K Buy
+22,203
New +$754K 0.05% 392

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quadrature Capital's HCAT Position: Q1 2026 in Review

Quadrature Capital sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 26,888 shares — an estimated $64.3K sold.

Quadrature Capital first reported a position in HCAT in Q3 2020 and held it in 10 quarters. The position peaked at $1.64M in Q3 2022. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Quadrature Capital reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 26,888 Health Catalyst shares in Q1 2026, an estimated $64.3K.
  • Quadrature Capital first reported a position in Health Catalyst in Q3 2020 and held it in 10 quarters.
  • Quadrature Capital's Health Catalyst position peaked at $1.64M in Q3 2022.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.